Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.50 USD | -3.14% |
|
+3.32% | +0.26% |
Chart calendar Harmony Biosciences Holdings, Inc.
4d9.Yp3aeUI6XyrakBPWwsjnsTV67UJkc36ewwejA5PL2Vg.MdCwABdoCn2o0mOitYOM6UQVlAsSASnt7kHbWqvmjwAv3p4sDww2E4vkJw~b36f18c72db4e66d5ef1b1f58a90cd31
Upcoming events on Harmony Biosciences Holdings, Inc.
Past events on Harmony Biosciences Holdings, Inc.
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 438 437 0.23% | 582 582 0.03% | 715 715 0% | 840 | 993 | 1 191 |
EBITDA Million USD | Released Forecast Spread | 144 161 -11% | 216 241 -10.22% | 215 208 3.38% | 299 | 360 | 423 |
EBIT Million USD | Released Forecast Spread | 120 118 2.26% | 192 199 -3.72% | 191 205 -6.81% | 268 | 337 | 433 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 105 102 3.07% | 173 174 -0.51% | 192 194 -0.91% | 247 | 308 | 419 |
Net income Million USD | Released Forecast Spread | 181 168 7.83% | 129 139 -6.98% | 145 149 -2.46% | 202 | 251 | 325 |
EPS USD | Released Forecast Spread | 2,97 2,74 8.3% | 2,13 2,17 -1.84% | 2,51 2,36 6.58% | 3,27 | 4,02 | 5,28 |
Announcement Date | 21/02/23 | 22/02/24 | 25/02/25 | - |
Quarterly results
Fiscal Period | March | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 160 149 7.85% | 168 168 0.09% | 155 154 0.34% | 173 173 0.17% | 186 184 1.08% | 201 201 0.01% | 185 182 1.35% | 204 | 218 | 235 | 221 | 243 | 260 | 268 |
EBITDA Million USD | Released Forecast Spread | 61,7 71,5 -13.77% | 62,2 59,7 4.23% | 74,8 | 76,6 | 83,2 | 54,9 | 70,0 | 79,6 | 97,8 | |||||
EBIT Million USD | Released Forecast Spread | 64,5 57,2 12.71% | 40,2 44,8 -10.33% | 52,0 48,9 6.48% | 21,4 -2,97 820.04% | 61,7 54,9 12.33% | 55,7 62,4 -10.66% | 56,2 48,7 15.5% | 64,1 | 68,8 | 75,1 | 71,4 | 80,9 | 85,8 | 89,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 51,8 52,9 -2.03% | 39,7 34,1 16.32% | 51,8 46,8 10.67% | 21,7 -5,09 526.49% | 62,2 51,3 21.08% | 56,2 57,9 -3.02% | 57,2 45,2 26.4% | 54,8 | 57,6 | 65,2 | 66,4 | 73,7 | 73,3 | 78,3 |
Net income Million USD | Released Forecast Spread | 38,5 41,1 -6.41% | 26,6 28,4 -6.43% | 38,3 35,2 8.79% | 11,6 -4,74 344.52% | 46,8 39,1 19.66% | 49,5 44,8 10.4% | 45,6 35,2 29.29% | 47,4 | 51,2 | 56,7 | 50,2 | 57,4 | 61,2 | 64,1 |
EPS USD | Released Forecast Spread | 0,63 0,65 -3.08% | 0,45 0,48 -6.01% | 0,67 0,60 10.87% | 0,20 -0,06 415.81% | 0,79 0,66 18.82% | 0,85 0,73 15.81% | 0,78 0,61 28.29% | 0,73 | 0,79 | 0,88 | 0,80 | 0,91 | 0,97 | 1,03 |
Announcement Date | 31/10/23 | 22/02/24 | 30/04/24 | 06/08/24 | 29/10/24 | 25/02/25 | 06/05/25 | - | - | - | - | - | - | - |
More events
Past sector events for Harmony Biosciences Holdings, Inc.
Today | EMCURE PHARMACEUTICALS LIMITED: Q4 2025 Earnings Release |
2025-05-20 | FDC LIMITED: Q4 2025 Earnings Release (Projected) |
2025-05-20 | CSPC PHARMACEUTICAL GROUP LIMITED: Q1 2025 Earnings Release (Projected) |
2025-05-20 | MANKIND PHARMA LIMITED: Q4 2025 Earnings Release |
2025-05-20 07:48 am | TORRENT PHARMACEUTICALS LIMITED: Q4 2025 Earnings Release |
2025-05-20 07:36 am | GLAND PHARMA LIMITED: Q4 2025 Earnings Release |
2025-05-19 01:04 pm | PFIZER LIMITED: Q4 2025 Earnings Release |
2025-05-19 11:22 am | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2025 Earnings Release |
2025-05-19 11:20 am | MARKSANS PHARMA LIMITED: Q4 2025 Earnings Release |
2025-05-19 10:51 am | INNOVA CAPTAB LIMITED: Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HRMY Stock
- Calendar Harmony Biosciences Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions